‌

US Patent 11352321 Glucagon antagonists

Patent 11352321 was granted and assigned to METABASIS THERAPEUTICS, INC. on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

‌

METABASIS THERAPEUTICS, INC.

Current Assignee

‌

METABASIS THERAPEUTICS, INC.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11352321

Patent Inventor Names

Matthew P. Grote0

Mali Venkat Reddy0

Jorge E Gomez-Galeno0

Haiqing Li0

Zhili Sun0

Thanh Huu Nguyen0

Scott J. Hecker0

Robert Huerta Lemus0

...

Date of Patent

June 7, 2022

Patent Application Number

16289241

Date Filed

February 28, 2019

Patent Primary Examiner

CPC Code

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11352321 Glucagon antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API